AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2021

Apr 2, 2021

32777_dirs_2021-04-02_8ca9d3b0-3767-4ec5-9f61-9d4d3c2f6366.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-03-31

Reporting Person: Legault Pierre (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-31	Ordinary Shares	M	10000	$8.78	Acquired	10000	Direct
2021-03-31	Ordinary Shares	S	10000	$30.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-31	Stock Option (Right to Buy)	$8.78	M	10000	Disposed	2029-04-25	Ordinary Shares (10000)	Direct

Footnotes

F1: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.37827 to GBP 1.00 as of March 31, 2021.

F2: Shares were sold pursuant to a Rule 10b5-1 trading plan.

F3: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.